Immunitybio (IBRX) had the highest return between January 6, 2020 and January 22, 2020 by a mid-cap US stock, returning 85.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 1/6/2020 - 1/22/2020 | 85.38% |
Denali Therapeutics (DNLI) | 1/6/2020 - 1/22/2020 | 45.16% |
Hut 8 Corp Common Stock (HUT) | 1/6/2020 - 1/22/2020 | 45.13% |
Signet Jewelers (SIG) | 1/6/2020 - 1/22/2020 | 44.23% |
Ultragenyx (RARE) | 1/6/2020 - 1/22/2020 | 37.1% |
Soleno Therapeutics (SLNO) | 1/6/2020 - 1/22/2020 | 36.79% |
Apellis Pharmaceuticals (APLS) | 1/6/2020 - 1/22/2020 | 34.83% |
Impinj (PI) | 1/6/2020 - 1/22/2020 | 32.32% |
Appian (APPN) | 1/6/2020 - 1/22/2020 | 30.74% |
Xenon Pharmaceuticals (XENE) | 1/6/2020 - 1/22/2020 | 27.98% |
Novocure (NVCR) | 1/6/2020 - 1/22/2020 | 27.35% |
iRhythm Technologies (IRTC) | 1/6/2020 - 1/22/2020 | 27.35% |
Celsius (CELH) | 1/6/2020 - 1/22/2020 | 25.98% |
Merus (MRUS) | 1/6/2020 - 1/22/2020 | 25.44% |
TG Therapeutics (TGTX) | 1/6/2020 - 1/22/2020 | 25.21% |
Zai Lab (ZLAB) | 1/6/2020 - 1/22/2020 | 24.28% |
Bill Com (BILL) | 1/6/2020 - 1/22/2020 | 23.95% |
Camtek (CAMT) | 1/6/2020 - 1/22/2020 | 23.29% |
Teladoc (TDOC) | 1/6/2020 - 1/22/2020 | 23.13% |
Akero Therapeutics (AKRO) | 1/6/2020 - 1/22/2020 | 22.56% |
ADMA Biologics (ADMA) | 1/6/2020 - 1/22/2020 | 21.22% |
Lumen Technologies (LUMN) | 1/6/2020 - 1/22/2020 | 20.37% |
Perrigo (PRGO) | 1/6/2020 - 1/22/2020 | 19.94% |
APA (APA) | 1/6/2020 - 1/22/2020 | 19.92% |
Lattice Semiconductor (LSCC) | 1/6/2020 - 1/22/2020 | 19.87% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
